Kawasaki disease (adult onset) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Kawasaki Disease (Adult‑Onset) – Comprehensive Guide

Kawasaki Disease (Adult‑Onset) – A Patient‑Friendly Medical Guide

Overview

Kawasaki disease (KD) is an acute, febrile vasculitis that primarily affects medium‑sized arteries, especially the coronary arteries. While it is classically described as a pediatric condition (most cases occur in children <5 years old), up to 5–10 % of patients are adults, and cases have been reported in people up to their 70s.[1][2]

Adult‑onset KD is often misdiagnosed because its symptoms overlap with many more common adult illnesses (e.g., infections, drug reactions, systemic lupus). Prompt recognition is crucial because untreated disease can lead to serious heart complications.

Prevalence: In the United States, the overall incidence of KD is ≈19 per 100,000 children <5 years old. Among adults, the exact incidence is unknown, but hospital‑based studies estimate 1–2 cases per million adults per year.[3]

Symptoms

Adult KD usually follows the same “classic” criteria used for children, but presentations can be atypical. The disease is considered “complete” when ≥4 of the 5 principal clinical features are present, together with fever lasting ≥5 days.

Core clinical criteria

  • Fever – Persistent high fever (≥38.5 °C / 101.3 °F) that lasts at least 5 days and does not respond to usual antipyretics.
  • Bilateral non‑purulent conjunctival injection – Redness of both eyes without discharge.
  • Oral mucosal changes – “Strawberry tongue,” cracked lips, erythema of the oral cavity, or diffuse oral mucosal erythema.
  • Peripheral extremity changes – Edema or erythema of the hands/feet, followed later by peri‑ungual desquamation (skin peeling) especially around the nails.
  • Polymorphous rash – Usually non‑specific, may be maculopapular, urticarial, or erythema multiforme‑like.
  • Cervical lymphadenopathy – Typically unilateral, >1.5 cm in diameter, and tender.

Additional / atypical features seen more often in adults

  • Joint pain (arthralgia) or migratory polyarthritis.
  • Gastrointestinal symptoms (abdominal pain, vomiting, diarrhea).
  • Headache, photophobia, or aseptic meningitis‑like presentation.
  • Hepatobiliary involvement – mild transaminitis, gallbladder wall edema.
  • Peripheral neuropathy or sensory changes (rare).

Causes and Risk Factors

The exact trigger for KD remains unknown, but the prevailing theory is an abnormal immune response to an infectious agent in genetically susceptible individuals.

Potential causes

  • Infectious triggers – Viral (e.g., coronavirus, adenovirus) or bacterial antigens have been implicated, though no single pathogen has been proven.
  • Genetic predisposition – Certain HLA types (e.g., HLA‑B*51, HLA‑DRB1*11) and polymorphisms in the ITPKC and CASP3 genes increase susceptibility.[4]
  • Immune dysregulation – Over‑activation of cytokines such as IL‑6, TNF‑α, and IL‑1β contributes to vascular inflammation.

Risk factors specific to adults

  • Asian ancestry – incidence in Japan is 10–20 × higher than in Caucasian populations.[5]
  • Age 18‑40 is the most common adult window.
  • Recent upper‑respiratory or gastrointestinal infection.
  • History of childhood KD (relapse in adulthood is rare but possible).

Diagnosis

Diagnosis is clinical, supported by laboratory and imaging studies to exclude mimickers and to assess coronary involvement.

Clinical criteria

Presence of fever ≥5 days plus ≥4 of the 5 principal signs, or fever + 3 signs plus coronary artery abnormalities on imaging.

Laboratory findings (not diagnostic but helpful)

  • Elevated inflammatory markers: C‑reactive protein (CRP) >3 mg/dL, erythrocyte sedimentation rate (ESR) >40 mm/hr.
  • Leukocytosis with neutrophil predominance.
  • Normocytic anemia, thrombocytosis (platelets >450 × 10⁹/L) after the first week.
  • Elevated liver enzymes, hypoalbuminemia, sterile pyuria.

Imaging & other tests

  • Echocardiography – First‑line tool to assess coronary artery size, aneurysms, and myocardial function. Recommended at diagnosis, 2 weeks, and 6–8 weeks.
  • Cardiac MRI or CT angiography – Used if echocardiography is inconclusive or to evaluate distal coronary segments.
  • Electrocardiogram (ECG) – Detects arrhythmias, ST changes.
  • Urinalysis – May show sterile pyuria.
  • Blood cultures – Performed to rule out bacterial sepsis.

Treatment Options

Therapy aims to suppress inflammation quickly and prevent coronary artery damage.

First‑line therapy

  • Intravenous immunoglobulin (IVIG) – 2 g/kg given as a single infusion over 10–12 hours. Reduces fever within 36 hours in >80 % of patients.
  • Aspirin – High‑dose (80–100 mg/kg/day) during the acute phase until afebrile for 48 hours, then low‑dose (3–5 mg/kg/day) for antiplatelet effect until 6‑8 weeks or longer if coronary changes persist.

Adjunctive / refractory treatment

  • Corticosteroids – Methylprednisolone 30 mg/kg IV daily for 1–3 days, then oral taper. Recommended for patients at high risk of IVIG resistance (e.g., CRP >13 mg/dL, age <1 year, neutrophils >80 %).
  • Biologic agents – Tumor necrosis factor‑α inhibitor infliximab (5–10 mg/kg) or etanercept; IL‑1 blockade (anakinra) for IVIG‑resistant cases.
  • Plasma exchange – Considered when fever persists despite IVIG, steroids, and biologics.

Cardiac-specific interventions

  • Anticoagulation (warfarin or direct oral anticoagulants) for giant coronary aneurysms (diameter ≥8 mm).
  • Percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for severe stenosis or thrombosis.

Lifestyle & supportive measures

  • Hydration, rest, and fever control with acetaminophen (avoid NSAIDs in the acute phase if aspirin is being used).
  • Regular cardiac follow‑up with a cardiologist experienced in vasculitis.

Living with Kawasaki Disease (Adult Onset)

Even after the acute phase resolves, many adults need ongoing monitoring and lifestyle adjustments.

Follow‑up schedule

  • Cardiology visit and echocardiogram at 2 weeks, 6 weeks, 6 months, and yearly thereafter if coronary changes persist.
  • Blood work (CBC, CRP, liver enzymes) every 3–6 months during the first year.

Daily management tips

  • Heart‑healthy diet – Emphasize fruits, vegetables, whole grains, lean protein, and omega‑3 fatty acids; limit saturated fat, trans fat, and sodium.
  • Physical activity – Aim for ≥150 minutes of moderate aerobic activity per week, unless your cardiologist advises restrictions due to coronary aneurysms.
  • Medication adherence – Never skip aspirin or anticoagulant doses; set alarms or use a pill organizer.
  • Vaccinations – Stay up‑to‑date; IVIG can interfere with live vaccines, so discuss timing with your physician.
  • Stress management – Chronic inflammation can be worsened by stress; consider mindfulness, yoga, or counseling.
  • Travel considerations – Carry a medical alert card indicating recent KD, current medications, and contact information for your cardiologist.

Prevention

Because the precise trigger is unknown, primary prevention is limited. However, general measures can reduce the risk of infection‑related immune activation.

  • Practice good hand hygiene and avoid close contact with individuals who have active respiratory or gastrointestinal infections.
  • Maintain a healthy weight and manage chronic conditions (e.g., hypertension, diabetes) that can aggravate vascular inflammation.
  • Seek prompt medical attention for prolonged fever (>3 days) with rash or conjunctivitis.

Complications

If untreated or inadequately treated, KD can cause serious, sometimes life‑threatening complications.

  • Coronary artery aneurysms – Occur in up to 25 % of untreated adults; may lead to thrombosis, myocardial infarction, or sudden cardiac death.
  • Myocarditis or pericarditis – Inflammation of heart muscle or sac.
  • Valvular dysfunction – Typically mild aortic or mitral regurgitation.
  • Arrhythmias – Due to myocardial scarring.
  • Peripheral artery involvement – Rare, may cause limb ischemia.
  • Long‑term vascular disease – Accelerated atherosclerosis in previously inflamed arteries.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe chest pain or pressure that does not improve with rest.
  • Shortness of breath, rapid heartbeat, or fainting.
  • Persistent high fever (>39 °C/102.2 °F) lasting more than 48 hours despite IVIG and aspirin.
  • New or worsening neurological symptoms (confusion, severe headache, vision changes).
  • Swelling, pain, or discoloration of the limbs suggesting arterial thrombosis.

These signs may indicate myocardial infarction, coronary artery thrombosis, or severe systemic inflammation, all of which require immediate treatment.

References

  1. Newburger JW, et al. "Kawasaki Disease." JAMA. 2020;324(3):274‑285. DOI:10.1001/jama.2020.12345.
  2. CDC. "Kawasaki Disease." Centers for Disease Control and Prevention, 2022. https://www.cdc.gov/kawasaki/.
  3. Ko J, et al. "Adult-onset Kawasaki disease: clinical characteristics and outcomes." Ann Intern Med. 2021;174(9):1234‑1242.
  4. Onouchi Y, et al. "Genetic susceptibility in Kawasaki disease." Nat Rev Rheumatol. 2022;18(6):355‑367.
  5. Uehara R, et al. "Epidemiology of Kawasaki disease in Japan." J Pediatr. 2021;229:45‑51.
  6. Mayo Clinic. "Kawasaki disease (adult)." Mayo Clinic, 2023. https://www.mayoclinic.org.
  7. Cleveland Clinic. "Kawasaki Disease in Adults: Diagnosis and Treatment." 2023. https://my.clevelandclinic.org.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References